Henry S. Tilney
Papers
9
Total Citations
1,525
H-Index
7
About
Henry S. Tilney is a pioneering colorectal surgeon whose research has significantly advanced the field of minimally invasive and robotic surgery, with a particular focus on rectal cancer treatment. His most impactful contribution is his involvement in the landmark ROLARR trial, published in 2017, which directly compared robotic-assisted and conventional laparoscopic surgery for rectal cancer resection — a study that has garnered an extraordinary 1,341 citations and has become a cornerstone reference in surgical oncology worldwide. Tilney's work extends beyond clinical trials into the evaluation of emerging surgical technologies, including preclinical assessment of the Versius robotic system and studies examining the role of indocyanine green fluorescence angiography in reducing anastomotic leaks — one of the most feared complications in rectal surgery. He has also contributed meaningfully to surgical education, examining the current landscape of robotic colorectal training programmes. During the COVID-19 pandemic, Tilney demonstrated clinical leadership by establishing and reporting on "COVID-protected" robotic surgical units, ensuring continuity of cancer care during unprecedented disruption. Collectively, his body of work reflects a career dedicated to improving surgical safety, advancing robotic technique, and shaping how the next generation of colorectal surgeons are trained.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3The current status of robotic colorectal surgery training programmes33 citations · 2022
- 4
- 5
- 6
- 7
- 8Short Term Pathology Results from the First World Wide Randomised Trial of Robotic Versus Laparoscopic Resection for Rectal Cancer (ROLARR)3 citations · 2016
- 9Robotic Total Mesorectal Excision1 citations · 2019